Given the ability of heparanase to modulate pro-inflammatory cytokine levels (3, 60), and activate and recruit tumor-promoting leukocytes (34, 54), it is likely that heparanase plays a greater role in modulating the immune system and immune suppression during cancer progression. The gene discussed is HPSE; the disease is cancer.